Home › Funds › BVF INC/IL › IVA
BVF INC/IL position in IVA
INVENTIVA SA · Health Care
BVF INC/IL reported holding 686,040 shares of IVA (INVENTIVA SA) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.07% of its reported portfolio and ranking #43 among its reported holdings. BVF INC/IL has disclosed IVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's IVA position evolved
BVF INC/IL first disclosed a stake in IVA in Q3 2023 at 686,040 shares (US$2.9M). The position peaked in Q3 2025 at 686,040 shares, worth US$4.0M. Across 12 filings, BVF INC/IL held the position steady without any share-count change. The most recent filing (Q2 2026) shows 686,040 shares valued at US$2.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 686.04K | $2.88M | New |
| Q4 2023 | 686.04K | $3.07M | Hold |
| Q1 2024 | 686.04K | $2.48M | Hold |
| Q2 2024 | 686.04K | $2.02M | Hold |
| Q3 2024 | 686.04K | $1.27M | Hold |
| Q4 2024 | 686.04K | $1.47M | Hold |
| Q1 2025 | 686.04K | $2.06M | Hold |
| Q2 2025 | 686.04K | $2.14M | Hold |
| Q3 2025 | 686.04K | $3.97M | Hold |
| Q4 2025 | 686.04K | $3.19M | Hold |
| Q1 2026 | 686.04K | $3.81M | Hold |
| Q2 2026 | 686.04K | $2.59M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IVA and 13F data
IVA (INVENTIVA SA) is a Health Care company. 94 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IVA
- Caligan Partners LP 8.16M sh · $30.86M · Q2 2026
- Samsara BioCapital, LLC 6.31M sh · $23.87M · Q2 2026
- Paradigm Biocapital Advisors LP 4.00M sh · $15.12M · Q2 2026
- ADAR1 Capital Management, LLC 3.61M sh · $13.63M · Q2 2026
- Andera Partners 3.63M sh · $13.41M · Q3 2026
- SymBiosis Capital Partners, LLC 2.35M sh · $13.06M · Q1 2026
- Trails Edge Capital Partners, LP 2.66M sh · $10.05M · Q2 2026
- Squadron Capital Management LLC 2.44M sh · $9.20M · Q2 2026
- Patient Square Capital LP 1.97M sh · $7.44M · Q2 2026
- NEXTBio Capital Management LP 1.79M sh · $6.76M · Q2 2026
- Yu Fan 1.50M sh · $5.67M · Q2 2026
- NEA Management Company, LLC 1.46M sh · $5.53M · Q2 2026
More on BVF INC/IL
FAQ
How long has BVF INC/IL held IVA?
BVF INC/IL has disclosed IVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in IVA?
As of Q2 2026, BVF INC/IL holds 686.04K shares of IVA (INVENTIVA SA), valued at $2.59M, representing 0.07% of its reported portfolio and ranking #43.
Has BVF INC/IL been buying or selling IVA?
In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in IVA. The position peaked in Q3 2025 at 686.04K shares.
Which other funds hold IVA?
Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.